KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,845,441 | -63.8% | 204,708 | -40.1% | 0.00% | -50.0% |
Q2 2023 | $7,852,120 | -10.7% | 341,545 | +15.1% | 0.00% | 0.0% |
Q1 2023 | $8,795,458 | +4.3% | 296,843 | -12.2% | 0.00% | 0.0% |
Q4 2022 | $8,434,733 | +15.1% | 337,930 | +0.3% | 0.00% | 0.0% |
Q3 2022 | $7,331,000 | +34.3% | 336,759 | +21.5% | 0.00% | +100.0% |
Q2 2022 | $5,459,000 | -47.1% | 277,264 | +13.7% | 0.00% | -50.0% |
Q1 2022 | $10,323,000 | -39.3% | 243,926 | -8.9% | 0.00% | -33.3% |
Q4 2021 | $17,002,000 | +60.6% | 267,790 | +48.6% | 0.00% | +50.0% |
Q3 2021 | $10,585,000 | +172.7% | 180,207 | +125.3% | 0.00% | +100.0% |
Q2 2021 | $3,881,000 | +589.3% | 80,003 | +451.9% | 0.00% | – |
Q1 2021 | $563,000 | -67.5% | 14,496 | -48.1% | 0.00% | – |
Q4 2020 | $1,732,000 | -63.7% | 27,930 | -81.1% | 0.00% | -100.0% |
Q3 2020 | $4,773,000 | – | 147,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
AtonRa Partners | 34,462 | $750,000 | 0.74% |
Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |